Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons E.A.M. Festen

Publicaties

Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease

Health-related quality of life is linked to the gut microbiome in kidney transplant recipients

Health-Related Quality of Life is Linked to the Gut Microbiome in Kidney Transplant Recipients

Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures

Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study

Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn's disease

Cigarette smoke increases risk for colorectal neoplasia in inflammatory bowel disease

Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation

Lees meer

Pers/media

Effectiviteit van medicijnen voorspellen bij chronische darmziekte colitis ulcerosa